May 7, 2019
Dear Customer:
As you may recall, the U.S. Federal Trade Commission challenged the September 2017 merger between Freedom Innovations and Ottobock, arguing that the combination would create an anticompetitive position within microprocessor-controlled knee products for patients. Recently, Administrative Law Judge D. Michael Chappell issued an Initial Decision on the matter in support of the FTC’s position.
It is important to know that this latest development is just that – a development in the case. It is not a final decision and it does not decide the ultimate outcome of the case. We do not know when this case will be settled as a final matter, but this latest interim step has no bearing on and does not impact Freedom’s operations, products, customer relationships or other agreements. We will continue to compete vigorously and operate as an independent entity. The structure, resources, personnel – and most importantly, the mission – of Freedom remain unchanged.
If you have any questions regarding this matter, please do not hesitate to contact your local Freedom representative and we will address any concerns or questions promptly.
We remain focused on our Mission: providing people with physical challenges the ability to achieve their full potential. All of us at Freedom Innovations sincerely appreciate your continued support of our company, people, and products.
Best Regards,
Dave Reissfelder
Chief Executive Officer
3 Morgan, Irvine CA 92618 toll-free 888.818.6777 Tel 949.672.0032 fax 949.672.0084 www.freedom-innovations.com
